Delivery Order SPE2DB20D1050-SPE2DB25FH79N
- Not listed
- The Defense Logistics Agency awarded a $5,640.36 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for Norditropin FlexPro 15 mg/1.5 mL pharmaceutical product, with an ultimate completion date of July 28, 2025. This is a firm fixed-price, non-set-aside contract with performance in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $2,922.70 for the supply of Norditropin FlexPro 15 mg/1.5 1.5 mL. The contract has a completion date of January 31, 2024. Amerisourcebergen Drug Corp, located in Conshohocken, Pennsylvania, is the prime contractor on this delivery order. No set-aside designation was used for this contract...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Norditropin Flexpro 10 mg/1.5 1.5 mL pharmaceutical products. The $6,208.52 order has a completion date of February 15, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,012.68 firm-fixed-price delivery order to AmerisourceBergen Drug Corporation's Corporate Office division for the supply of NORDITROPIN FLEXPRO 15 MG/1.5 1.5ML. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, which enables the DLA to procure a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. AmerisourceBergen,...
- The Defense Logistics Agency awarded a $21,466.53 delivery order to AmerisourceBergen Drug Corp for the supply of Norditropin FlexPro 15 mg/1.5 mL, a human growth hormone medication. This competitively awarded, firm fixed-price delivery order was issued on July 21, 2025, with an ultimate completion date of July 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating open...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide NORDITROPIN FLEXPRO 10 MG/1.5 1.5ML pharmaceutical products. The order has a potential value of $1,624.22 and a completion date of January 31, 2024. Amerisourcebergen Drug Corp is a prime contractor that holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00, to deliver a wide range of pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563266072 NORDITROPIN FLEXPRO 15 MG/1.5 1.5ML pharmaceutical products. The $1,753.62 order has a completion date of January 9, 2024 and was awarded on January 8, 2024. Amerisourcebergen Drug Corp has a history of providing pharmaceuticals, medical supplies, and distribution services to support DLA Troop Support Medical programs....
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,145.42, is for the delivery of Norditropin FlexPro 15 mg/1.5 ml, a medication used to treat growth hormone deficiencies. The contract has an ultimate completion date of April 16, 2025 and is not set aside for any particular business category. AmerisourceBergen Drug Corp holds a...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of NORDITROPIN FLEXPRO 15 MG/1.5 1.5ML, a pharmaceutical product. The award has a potential value of $3,507.24 and a completion date of January 31, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this contract. This delivery order is issued under a larger indefinite delivery...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $5,552.94 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of NORDITROPIN FLEXPRO 15 MG/1.5 1.5ML. This order is part of a larger contract vehicle between Amerisourcebergen Drug Corp and DLA Troop Support Medical to provide pharmaceuticals and medical supplies in support of military treatment programs and facilities. The contract does not have a set-aside designation....
- SPE2DB20D1050Indefinite Delivery Contract
- SPE2DB20D1050-SPE2DB25FH79NDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,396.92 to AmerisourceBergen Drug Corp for Norditropin FlexPro 15 mg/1.5 mL pharmaceutical product. This firm fixed-price delivery order, issued on July 24, 2025, represents a non-competitive set-aside award and is scheduled for completion by July 25, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 potential value through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement through its extensive portfolio of pharmaceutical products and medical supplies supporting military and veteran healthcare systems. The company's DLA contract vehicle enables it to supply a comprehensive range of medications, vaccines, and medical devices across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare customers globally. This specific delivery order for Norditropin, a growth hormone treatment, reflects the company's role in maintaining pharmaceutical supply chain support for federal medical programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 7/24/25 |